Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of alpha7 nicotinic choline receptor agonist in preparation of peptidyl arginine deiminase 4 inhibitor

A technology of peptide acyl arginine deiminase and choline receptor, which is applied in the field of α7 nicotinic choline receptor agonists in the field of preparing peptide acyl arginine deiminase 4 inhibitors, and can solve clinical problems. Efficacy remains to be verified, etc.

Pending Publication Date: 2022-02-11
CHINA PHARM UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These compounds are in the preclinical research stage, and the clinical efficacy is yet to be verified

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of alpha7 nicotinic choline receptor agonist in preparation of peptidyl arginine deiminase 4 inhibitor
  • Application of alpha7 nicotinic choline receptor agonist in preparation of peptidyl arginine deiminase 4 inhibitor
  • Application of alpha7 nicotinic choline receptor agonist in preparation of peptidyl arginine deiminase 4 inhibitor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Inhibitory effect of α7 nicotinic acetylcholine receptor agonist on the expression of PAD4 in macrophages

[0022] RAW264.7 cells were treated with 1×10 5 / mL density was seeded in 12-well plates, and the cells were placed at 37°C, 5% CO 2 After culturing in an incubator for 1 h, α7nAChR agonists PNU-282987, AR-R17779 (5, 10, 20 μM) and sinomenine (SIN, 0.25, 0.5, 1 mM) were added to the cell culture medium, respectively. After 30 min, phorbol ester (phorbol-12-myristate-13-acetate, PMA) or lipopolysaccharide (LPS, 1 μg / mL) was added to the cell culture medium. After 4 hours, the total protein of the cells was extracted, and the expression level of PAD4 was detected by Western blot. See the experimental results figure 1 , PNU-282987 (10, 20 μM), AR-R17779 (10, 20 μM), and sinomenine (0.5, 1 mM) significantly inhibited the expression of PAD4 in macrophages.

[0023] The experimental results showed that α7nAChR agonists significantly down-regulated the expression leve...

Embodiment 2

[0025] Inhibitory effect of α7nAChR agonists on the accumulation of intracellular catalytic products of PAD4

[0026] RAW264.7 cells were treated with 1×10 5 / mL density was seeded in 12-well plates, and the cells were placed at 37°C, 5% CO 2 After culturing in an incubator for 1 h, α7nAChR agonists PNU-282987, AR-R17779 (5, 10, 20 μM) and sinomenine (SIN, 0.25, 0.5, 1 mM) were added to the cell culture medium. After 30 min, PMA or LPS (1 μg / mL) was added to the medium. After 4 hours, the total cell protein was extracted, and the accumulation level of the intracellular catalytic product of PAD4 (citrullinated histone H3) was detected by Western blot. See the experimental results figure 2 , PNU-282987 (10, 20μM), AR-R17779 (10, 20μM), sinomenine (0.5, 1mM) significantly decreased the citrullination level of histone H3 in macrophages.

[0027] The test results showed that α7nAChR agonists significantly down-regulated the citrullination level of histone H3 in macrophages, an...

Embodiment 3

[0029] Inhibition of PAD4 activity by α7nAChR agonists

[0030] The α7nAChR agonists PNU-282987 (0.25, 0.5, 1, 2, 4, 8mM), AR-R17779 (0.25, 0.5, 1, 2, 4, 8mM), sinomenine (SIN, 1, 2, 4, 8, 16, 32mM) were added to the reaction buffer containing 100mM Tris (pH 7.2), 10mM calcium chloride, 10mM DL-dithiothreitol and 0.2ml recombinant PAD4 solution, and incubated at 37°C for 2min. A short peptide containing arginine and 10 mM N-α-benzoyl arginine ethyl ester were added to start the reaction, and then the reaction system was incubated at 37° C. for 30 min. The enzymatic reaction was terminated by adding 60% (w / v) perchloric acid. Ammonium ferrous sulfate hexahydrate and ammonium ferric sulfate dodecahydrate in 1N H 2 SO 4 The redox reagent prepared in was added to the reaction mixture, and then boiled for 10 min. After cooling to room temperature, the acid mixture (phosphoric acid, sulfuric acid and deionized water) and 12.5 mM 2,3-butanedione monoxime solution were added. Aft...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of an alpha7 nicotinic choline receptor agonist in preparation of a peptidyl arginine deiminase 4 inhibitor, the alpha7 nAChR agonist and PAD4 expression and activity are subjected to experimental research for the first time, and results prove that the alpha7 nAChR agonist inhibits PAD4 expression and activity. The invention discloses a good application prospect of the alpha 7nAChR agonist in preparation of drugs for treating PAD4 related diseases.

Description

technical field [0001] The present invention relates to the use of a class of compounds, in particular to the use of α7 nicotinic choline receptor agonists in the preparation of peptidyl arginine deiminase 4 inhibitors. Background technique [0002] Peptidylarginine deiminase 4 (peptidylarginine deiminase 4, PAD4) is a member of the PAD family. It is distributed in cells such as macrophages, granulocytes, and monocytes. protein, transforming positively charged histone arginine into electrically neutral citrulline residues, thereby weakening the interaction between histone and negatively charged DNA, loosening chromatin, breaking the nuclear membrane, and releasing loose Chromatin and granule proteins, eventually forming a network. PAD4 is an important protein post-translational modification enzyme, which is related to various cellular activities and functions. [0003] PAD4 is highly expressed in various tumors such as breast cancer, rectal adenocarcinoma, esophageal adeno...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/00A61K31/485A61K31/439A61P37/02A61P35/00A61P9/00
CPCA61K45/00A61K31/485A61K31/439A61P37/02A61P35/00A61P9/00
Inventor 戴岳吕长军夏玉凤魏志凤
Owner CHINA PHARM UNIV